Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?-Reference-Cited by-同舟云学术

Contemporary Treatment Patterns for Non-muscle-invasive Bladder Cancer: Has the Use of Radical Cystectomy Changed in the BCG Shortage Era?

Published:2021-01 Issue: Volume:147 Page:199-204
ISSN:0090-4295
Container-title:Urology
language:en
Short-container-title:Urology

Author:

Tully Karl H.,Cole Alexander P.,Krimphove Marieke J.,Friedlander David F.,Mossanen Matthew,Herzog Peter,Noldus Joachim,Sonpavde Guru P.,Trinh Quoc-Dien

Publisher

Elsevier BV

Subject

Urology

Reference30 articles.

1. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old;Comperat;Virchows Arch,2015

2. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

3. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016;Babjuk;Eur Urol,2017

4. NCCN guidelines insights: bladder cancer, version 5.2018;Flaig;J Natl Compr Canc Netw,2018

5. Intravesical bacille Calmette-Guerin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression;Bohle;Urology,2004

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world efficacy of adjuvant single-agent intravesical gemcitabine for non-muscle invasive bladder cancer;Expert Opinion on Pharmacotherapy;2023-10-19

2. Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage;Urology;2023-07

3. Novel Zebrafish Patient-Derived Tumor Xenograft Methodology for Evaluating Efficacy of Immune-Stimulating BCG Therapy in Urinary Bladder Cancer;Cells;2023-02-03

4. Cost-Effectiveness of Nadofaragene Firadenovec and Pembrolizumab in Bacillus Calmette-Guérin Immunotherapy Unresponsive Non–Muscle Invasive Bladder Cancer;Value in Health;2022-12

5. Gender, Bladder Cancer Healthcare and Burden of COVID-19;Cancer Investigation;2022-11-02